直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Media Mention

Litigators of the Week: Shout Out

October 22, 2021

The AmLaw Litigation Daily

The AmLaw Litigation Daily highlighted Finnegan attorneys Charles Lipsey, John Livingstone, Jill MacAlpine, David Weingarten, Ryan O’Quinn, Matt Hlinka, and Megan Meyers for their District of Delaware bench trial win on behalf of client AstraZeneca. The ruling protected AstraZeneca’s FARXIGA drug products against generic competition, stating the opposition failed to prove AstraZeneca’s patent claims were invalid due to obviousness.

Read “Litigators of the Week: Shout Out”

Tags

District of Delaware

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Offices

Washington, DC

Related Professionals

John D. Livingstone
Partner
Atlanta, GA
+1 404 653 6449
Email
M. David Weingarten, Ph.D.
Partner
Atlanta, GA
+1 404 653 6457
Email
Ryan P. O'Quinn, Ph.D.
Partner
Reston, VA
+1 571 203 2426
Email
Matthew J. Hlinka
Partner
Washington, DC
+1 202 408 4333
Email
Megan L. Meyers
Associate
Atlanta, GA
+1 404 653 6565
Email

Related News

Press Release

Finnegan Expands U.S. Platform with Launch of Dallas Office

September 2, 2026

Media Mention

Law360's Legal Lions of the Week: Volkswagen Group of America, Inc.

August 21, 2026

Commentary

Early Test of USPTO's Ex Parte Preorder Filing Leads to Re-Exam Denial

August 21, 2026

Award/Ranking

Fourteen Finnegan Attorneys Named to the 2026 IAM Strategy 300 List

August 13, 2026

Award/Ranking

Finnegan Named a Finalist for The American Lawyer 2026 Industry Awards

August 13, 2026

Award/Ranking

Finnegan Climbs Two Spots on The American Lawyer’s 2026: A-List Runners Up

August 12, 2026

Commentary

GenAI Patent Surge Extends Well Beyond Familiar Platform Firms

August 10, 2026

Commentary

Q&A: What the 'GenAI Boom' Means for Patents

August 6, 2026

Commentary

BMW Counsel: How a Supplier Clause Prevented U.S. Trade Secret Litigation

August 3, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP